Emmanuel Brown

About Emmanuel Brown

Emmanuel L. Brown is a litigation associate who represents major pharmaceutical and medical device companies in complex civil litigation, including mass tort and single-plaintiff actions. Read Emmanuel's full bio

FDA Warns Against Sales Representative’s “False and Misleading” Oral Statements Regarding Prescription Medicine

The U.S. Food and Drug Administration’s Office of Prescription Drug Promotion (OPDP) sent an untitled letter to Eisai Inc. on October 11, 2018, based on a sales representative’s “false and misleading” oral statements during a lunch presentation about the safety of the antiepileptic medication Fycompa®, downplaying warnings, and engaging in off-label promotion of the product.

Continue reading